Brandon Laidlaw
Board Member
Brandon is a seasoned executive and natural leader with a proven record of driving growth and innovation across pharmaceuticals and medical products. He is widely recognized for building strategic alliances, including close collaborations with Fortune 500 pharmaceutical manufacturers to deliver affordable medicines and critical medical products to federal and state governments. Brandon currently leads Medea Inc., where he oversees the company’s strategy, growth, and high‑performance culture in both pharmaceuticals and medical products. Under his leadership, Medea partners with key federal agencies such as Health and Human Services, the Department of Defense, the Department of Homeland Security, and multiple state governments, solidifying his reputation as a trusted and influential figure in the industry.
